contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


demant-as-investor-news-demant-owned-oticon-announces-the-launch-of-oticon-zealtm

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Demant operates in the medical technology sector. The company specializes in the development of hearing aids and hearing loops. The company operates on a global level where the products are sold under various brands. The products are available through the company's distributors and sales channels. In addition to its main business, the company conducts research in diagnostics for measuring hearing quality. The company was originally founded in 1904 and has its headquarters in Smörum.

Demant

22.10.2025 08:49:24 CEST | Demant A/S | Investor NewsInvestor news22 October 2025Demant-owned Oticon announces the launch of Oticon Zeal™ Today, at the European audiologist conference EUHA in...

22.10.2025 08:49:24 CEST | Demant A/S | Investor News<table class="prs-table"><tbody><tr><td>Investor news</td><td>22 October 2025</td></tr></tbody></table>Demant-owned Oticon announces the launch of Oticon Zeal™&nbsp;Today, at the European audiologist conference EUHA in Nuremberg, Germany, Oticon – part of Demant – is introducing Oticon Zeal™, which is a revolutionary new in-the-ear hearing aid style. In addition, Oticon is announcing an expansion of its Oticon Intent™ family with a rechargeable power miniBTE device.&nbsp;Demant is announcing the launch of new, groundbreaking hearing aid technology with the introduction of Oticon Zeal, a new in-the-ear hearing aid style, combining a discreet design, cutting-edge connectivity, rechargeability and exceptional sound quality, using AI sound processing with flexible fitting options. Oticon Zeal will be launched in phases and will initially be rolled out in several European markets in Q4 2025 followed by a global launch in 2026.&nbsp;In addition, Demant is expanding the Oticon Intent family with a new rechargeable power miniBTE, which is Oticon’s smallest power device and the world’s first miniBTE to combine two fitting levels in one device, allowing more flexibility when fitting hearing aid users. This product will be made available globally during Q4 2025. &nbsp;&nbsp;<h2>Adding leading connectivity standards</h2>With these introductions, Oticon is taking another important step in supporting modern connectivity standards by allowing users to seamlessly connect to their devices using Bluetooth™ LE Audio. As an industry first, Oticon hearing aids are now enabled for Google’s Fast Pair, allowing users to pair their hearing aid effortlessly with Android phones. In addition, Oticon Zeal and Oticon Intent now also feature Auracast™ technology, so users can experience a new world of audio.More details can be found in Oticon’s press releases <a href="https://www.oticon.global/about-us/press">here</a>.<table class="prs-table"><tbody><tr><td>Further information:Søren Nielsen, President &amp; CEOPhone +45 3917 7300<a href="http://www.demant.com">www.demant.com</a></td><td>Other contacts:René Schneider, CFOPeter Pudselykke, Head of Investor RelationsGustav Høegh, Investor Relations OfficerHenrik Axel Lynge Buchter, Manager of External Communications</td></tr></tbody></table>&nbsp;<h4>Contacts</h4><ul> <li> Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication &amp; Sustainability, +45 2264 9982, <a href="mailto:heey@demant.com">heey@demant.com</a> </li></ul><h4>About Demant A/S</h4>Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.<h4>Attachments</h4><ul> <li> <a href="https://via.ritzau.dk/ir-files/13560112/14633342/16423/Investor%20news%20-%20Introduction%20of%20Oticon%20Zeal.pdf">Investor news - Introduction of Oticon Zeal.pdf</a> </li></ul>

Demant A/S: Investor news - Demant-owned Oticon announces the launch of Oticon Zeal™